← Drug database

Clopidogrel Zentiva (previously Clopidogrel Winthrop) (clopidogrel)

Region
🇪🇺 EU
Active substance
clopidogrel
Company
Zentiva k.s.
Status
Authorised
Therapeutic area
Stroke; Peripheral Vascular Diseases; Myocardial Infarction; Acute Coronary Syndrome
CHMP opinion
Thu 24 Apr 2008
EU approval
Tue 15 Jul 2008
Application
EMEA/H/C/000975
ATC
B01AC04
Official record
www.ema.europa.eu

Indication

Secondary prevention of atherothrombotic events Clopidogrel is indicated in: adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from seven days until less than six months) or established peripheral arterial disease; adult patients suffering from acute coronary syndrome: non-ST-segment-elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA); ST-segment-elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy. Prevention of atherothrombotic and thromboembolic events in atrial fibrillation In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin-K antagonists and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke. For further information please refer to section 5.1.

Regulatory milestones

No milestones recorded in the last year.

Same substance in other markets

Follow Clopidogrel Zentiva (previously Clopidogrel Winthrop)

Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.